Medicine
Famciclovir 250 mg tablet
Famciclovir 250 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Famciclovir
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 5 blister pack, 1000 tablets and 10 more
- Manufacturers
- Camber PharmaceuticalsIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaAvKARERising Pharma HoldingsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AB09 Famciclovir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 September 2007
- Identifiers
- RxCUI 198382, 199192, 199193DailyMed set ID 08c58224-5920-4853-8c59-ec5fbb66c2f6, fcf0b0fa-bb2c-4f2c-aa9f-1f2da65d8343, d5c46506-a350-44a1-9440-d939da895f16 +4NDC 31722-707, 65862-466, 64980-350 +4Application ANDA202438, ANDA091114, ANDA201022 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 65862-466-30 | Aurobindo PharmaIndia | 21 March 2011 |
| 5 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-466-50 | Aurobindo PharmaIndia | 21 March 2011 |
| 1000 tablet, film coated in 1 bottle | 65862-466-99 | Aurobindo PharmaIndia | 21 March 2011 |
| 100 tablet, film coated in 1 bottle | 31722-707-01 | Camber PharmaceuticalsIndia | 10 September 2014 |
| 500 tablet, film coated in 1 bottle | 31722-707-05 | Camber PharmaceuticalsIndia | 10 September 2014 |
| 1000 tablet, film coated in 1 bottle | 31722-707-10 | Camber PharmaceuticalsIndia | 10 September 2014 |
| 30 tablet, film coated in 1 bottle | 31722-707-30 | Camber PharmaceuticalsIndia | 10 September 2014 |
| 60 tablet, film coated in 1 bottle | 31722-707-60 | Camber PharmaceuticalsIndia | 10 September 2014 |
| 30 tablet, film coated in 1 bottle | 33342-025-07 | Macleods PharmaceuticalsIndia | 13 January 2012 |
| 30 tablet, film coated in 1 bottle | 64980-350-03 | Rising Pharma Holdings | 21 March 2011 |
| 30 tablet, film coated in 1 bottle | 0093-8118-56 | Teva Pharmaceuticals | 5 September 2007 |
| 30 tablet, film coated in 1 bottle | 42291-415-30 | AvKARE | 19 May 2021 |
| 30 tablet, film coated in 1 bottle | 73190-092-30 | AvKARE | 21 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 29 June 1994 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Famciclovir
Clinical summary
Famciclovir is a herpesvirus nucleoside analog DNA polymerase inhibitor indicated for immunocompetent Adult Patients, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Famciclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FamciclovirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Famciclovir prescribing information (Macleods Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Famciclovir 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.